These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 18083572

  • 1. Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy.
    Walker DG, Laherty R, Tomlinson FH, Chuah T, Schmidt C.
    J Clin Neurosci; 2008 Feb; 15(2):114-21. PubMed ID: 18083572
    [Abstract] [Full Text] [Related]

  • 2. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.
    Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL.
    Cancer Res; 2001 Feb 01; 61(3):842-7. PubMed ID: 11221866
    [Abstract] [Full Text] [Related]

  • 3. Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report.
    De Vleeschouwer S, Van Calenbergh F, Demaerel P, Flamen P, Rutkowski S, Kaempgen E, Wolff JE, Plets C, Sciot R, Van Gool SW.
    J Neurosurg; 2004 May 01; 100(5 Suppl Pediatrics):492-7. PubMed ID: 15287461
    [Abstract] [Full Text] [Related]

  • 4. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H, Shurin MR, Han B.
    Expert Rev Vaccines; 2007 Jun 01; 6(3):333-45. PubMed ID: 17542749
    [Abstract] [Full Text] [Related]

  • 5. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
    De Vleeschouwer S, Fieuws S, Rutkowski S, Van Calenbergh F, Van Loon J, Goffin J, Sciot R, Wilms G, Demaerel P, Warmuth-Metz M, Soerensen N, Wolff JE, Wagner S, Kaempgen E, Van Gool SW.
    Clin Cancer Res; 2008 May 15; 14(10):3098-104. PubMed ID: 18483377
    [Abstract] [Full Text] [Related]

  • 6. Priming anticancer active specific immunotherapy with dendritic cells.
    Mocellin S.
    Curr Opin Investig Drugs; 2005 Jun 15; 6(6):576-81. PubMed ID: 15988908
    [Abstract] [Full Text] [Related]

  • 7. Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas.
    Tanaka F, Haraguchi N, Isikawa K, Inoue H, Mori M.
    Oncol Rep; 2008 Nov 15; 20(5):1111-6. PubMed ID: 18949409
    [Abstract] [Full Text] [Related]

  • 8. Vaccine therapy for renal cancer.
    Amato RJ.
    Expert Rev Vaccines; 2008 Sep 15; 7(7):925-35. PubMed ID: 18767943
    [Abstract] [Full Text] [Related]

  • 9. Galectin-1 and immunotherapy for brain cancer.
    Verschuere T, De Vleeschouwer S, Lefranc F, Kiss R, Van Gool SW.
    Expert Rev Neurother; 2011 Apr 15; 11(4):533-43. PubMed ID: 21469926
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours.
    Ardon H, De Vleeschouwer S, Van Calenbergh F, Claes L, Kramm CM, Rutkowski S, Wolff JE, Van Gool SW.
    Pediatr Blood Cancer; 2010 Apr 15; 54(4):519-25. PubMed ID: 19852061
    [Abstract] [Full Text] [Related]

  • 11. Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy.
    Royer PJ, Bougras G, Ebstein F, Leveque L, Tanguy-Royer S, Simon T, Juge-Morineau N, Chevallier P, Harousseau JL, Gregoire M.
    Exp Hematol; 2008 Mar 15; 36(3):329-39. PubMed ID: 18207305
    [Abstract] [Full Text] [Related]

  • 12. Optimal control in a model of dendritic cell transfection cancer immunotherapy.
    Castiglione F, Piccoli B.
    Bull Math Biol; 2006 Feb 15; 68(2):255-74. PubMed ID: 16794930
    [Abstract] [Full Text] [Related]

  • 13. Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients.
    Wheeler CJ, Black KL, Liu G, Mazer M, Zhang XX, Pepkowitz S, Goldfinger D, Ng H, Irvin D, Yu JS.
    Cancer Res; 2008 Jul 15; 68(14):5955-64. PubMed ID: 18632651
    [Abstract] [Full Text] [Related]

  • 14. Dendritic cell vaccines to combat glioblastoma.
    Wheeler CJ.
    Expert Rev Neurother; 2010 Apr 15; 10(4):483-6. PubMed ID: 20367199
    [No Abstract] [Full Text] [Related]

  • 15. Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2.
    Svane IM, Pedersen AE, Nikolajsen K, Zocca MB.
    Vaccine; 2008 Aug 26; 26(36):4716-24. PubMed ID: 18616968
    [Abstract] [Full Text] [Related]

  • 16. Astrocytoma in a breast cancer lineage: part of the BRCA2 phenotype?
    Wilson BT, Douglas SF, Polvikoski T.
    J Clin Oncol; 2010 Oct 20; 28(30):e596-8. PubMed ID: 20713847
    [No Abstract] [Full Text] [Related]

  • 17. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M, Wada J, Suzuki H, Tanaka M, Katano M, Morisaki T.
    Anticancer Res; 2009 Mar 20; 29(3):831-6. PubMed ID: 19414316
    [Abstract] [Full Text] [Related]

  • 18. Genetically modified dendritic cell-based cancer vaccines.
    Bubeník J.
    Folia Biol (Praha); 2001 Mar 20; 47(5):153-5. PubMed ID: 11686430
    [No Abstract] [Full Text] [Related]

  • 19. High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors.
    Peres E, Wood GW, Poulik J, Baynes R, Sood S, Abidi MH, Klein J, Bhambhani K, Dansey R, Abella E.
    Neuropediatrics; 2008 Jun 20; 39(3):151-6. PubMed ID: 18991194
    [Abstract] [Full Text] [Related]

  • 20. Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate.
    Soleimani A, Berntsen A, Svane IM, Pedersen AE.
    Scand J Immunol; 2009 Nov 20; 70(5):481-9. PubMed ID: 19874553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.